Overcoming Acquired Resistance to AZD9291, A Third-Generation EGFR Inhibitor, through Modulation of MEK/ERK-Dependent Bim and Mcl-1 Degradation.

Name: Overcoming Acquired Resistance to AZD9291, A Third-Generation EGFR Inhibitor, through Modulation of MEK/ERK-Dependent Bim and Mcl-1 Degradation.
Author: Shi, Puyu

Overcoming Acquired Resistance to AZD9291, A Third-Generation EGFR Inhibitor, through Modulation of MEK/ERK-Dependent Bim and Mcl-1 Degradation. — المؤلف: Shi, Puyu — Clinical cancer research : an official journal of the American Association for Cancer Research 20180723

المؤلف: Shi, Puyu
النشر: Clinical cancer research : an official journal of the American Association for Cancer Research 20180723
الوصف: 6567-6579 p.
الموضوعات: Acrylamides؛ Aniline Compounds؛ Animals؛ Apoptosis؛ Bcl-2-Like Protein 11؛ Carcinoma, Non-Small-Cell Lung؛ Drug Resistance, Neoplasm؛ ErbB Receptors